Suppr超能文献

过氧化物酶体增殖物激活受体β/δ(PPARβ/δ):蛛网膜下腔出血后大鼠血管平滑肌细胞表型调节和血管重构的新型调节因子。

PPARβ/δ, a Novel Regulator for Vascular Smooth Muscle Cells Phenotypic Modulation and Vascular Remodeling after Subarachnoid Hemorrhage in Rats.

机构信息

Department of Neurosurgery, the First Affiliated Hospital of Chongqing Medical University, NO. 1 of Youyi Rd, Yuzhong District, Chongqing, China.

Department of Neurosurgery, the Affiliated Hospital of Zunyi Medical College, NO. 149 of Dalian Rd, Zunyi, Guizhou, China.

出版信息

Sci Rep. 2017 Mar 22;7:45234. doi: 10.1038/srep45234.

Abstract

Cerebral vascular smooth muscle cell (VSMC) phenotypic switch is involved in the pathophysiology of vascular injury after aneurysmal subarachnoid hemorrhage (aSAH), whereas the molecular mechanism underlying it remains largely speculative. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) has been implicated to modulate the vascular cells proliferation and vascular homeostasis. In the present study, we investigated the potential role of PPARβ/δ in VSMC phenotypic switch following SAH. Activation of PPARβ/δ by GW0742 and adenoviruses PPARβ/δ (Ad-PPARβ/δ) significantly inhibited hemoglobin-induced VSMC phenotypic switch. However, the effects of PPARβ/δ on VSMC phenotypic switch were partly obstacled in the presence of LY294002, a potent inhibitor of Phosphatidyl-Inositol-3 Kinase-AKT (PI3K/AKT). Furthermore, following study demonstrated that PPARβ/δ-induced PI3K/AKT activation can also contribute to Serum Response Factor (SRF) nucleus localization and Myocardin expression, which was highly associated with VSMC phenotypic switch. Finally, we found that Ad-PPARβ/δ positively modulated vascular remodeling in SAH rats, i.e. the diameter of basilar artery and the thickness of vessel wall. In addition, overexpression of PPARβ/δ by adenoviruses significantly improved neurological outcome. Taken together, this study identified PPARβ/δ as a useful regulator for VSMC phenotypic switch and vascular remodeling following SAH, providing novel insights into the therapeutic strategies of delayed cerebral ischemia.

摘要

脑血管平滑肌细胞(VSMC)表型转换参与了蛛网膜下腔出血(aSAH)后血管损伤的病理生理学,但其潜在的分子机制仍在很大程度上被推测。过氧化物酶体增殖物激活受体β/δ(PPARβ/δ)被认为可以调节血管细胞的增殖和血管稳态。在本研究中,我们研究了 PPARβ/δ 在 aSAH 后 VSMC 表型转换中的潜在作用。通过 GW0742 和腺病毒 PPARβ/δ(Ad-PPARβ/δ)激活 PPARβ/δ,显著抑制了血红蛋白诱导的 VSMC 表型转换。然而,在存在磷脂酰肌醇-3 激酶-AKT(PI3K/AKT)的强效抑制剂 LY294002 的情况下,PPARβ/δ 对 VSMC 表型转换的作用部分受阻。此外,进一步的研究表明,PPARβ/δ 诱导的 PI3K/AKT 激活也有助于血清反应因子(SRF)核定位和肌球蛋白表达,这与 VSMC 表型转换高度相关。最后,我们发现 Ad-PPARβ/δ 可正向调节 aSAH 大鼠的血管重塑,即基底动脉的直径和血管壁的厚度。此外,腺病毒过表达 PPARβ/δ 可显著改善神经功能预后。总之,这项研究确定了 PPARβ/δ 是 aSAH 后 VSMC 表型转换和血管重塑的有用调节剂,为迟发性脑缺血的治疗策略提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4db4/5361085/acea8dc12c58/srep45234-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验